Initiated in 1999, the Heinz Nixdorf Recall Study involved 4,814 European participants. The results proved, for the first time, the connection between coronary calcifications and the risk of heart attack, according to scientists at the University Hospital in Essen. The finding by no means exhausted the potential inherent in the surveys. Subsidised until 2013, researchers are examining coronary…
Ongoing technical developments in computed tomography (CT) such as dual source CT have established coronary CT angiography (cCTA) as a robust non-invasive imaging test for the assessment of coronary artery disease. The most important advantage of cCTA over conventional catheter-based coronary angiography is that not only the coronary lumen but also the entire coronary artery wall is visualized…
The focus on Coronary artery disease – from genes to outcomes at ESC 2010 underlines the importance of CAD diagnosis on the scientific agenda. During the session ‘Multi modality imaging to detect coronary artery disease’, chaired by Professor JJ Bax, of the Cardiology Department at Leiden University Medical Centre, the Netherlands, experts will discuss, for example, the advantages of the…
When in 1992 Dr Luigi Marzio Biasucci, head of the Sub-intensive Care Unit at the Catholic University of the Sacred Heart in Rome, Italy, published with his team the first paper on C-reactive protein (CRP) in unstable angina, few people believed in the diagnostic power of biochemical features to measure the effects or progress of disease, illness, or a condition. Today, biomarker tests are part…
A team led by UK-based researchers has found that having diabetes doubles the risk of developing a wide range of blood vessel diseases, including heart attacks and different types of stroke. The consortium, headed by Dr Nadeem Sarwar and Professor John Danesh of the University of Cambridge, analysed data from the individual records on 700,000 people, each of whom was monitored for about a decade…
Alere International* has launched three new next generation products: Troponin I -- a single-analyte, improved sensitivity Troponin I (TnI) test; Cardio2 -- a two analyte panel consisting of the new Troponin I and BNP, and Cardio3 -- a three analyte panel consisting of the new Troponin I, BNP and CK-MB.
In Switzerland, they say, the clocks tick a little slower than elsewhere in the world. Not at Schiller AG in Baar, however: The company remains forever ahead of the times. Since 1971, physicist Alfred E Schiller, the company’s founder and managing director, has successfully shown competitors in the tough intensive and emergency care market what innovative progress really means.
If patients suffering acute myocardial infarction, heart failure, or pneumonia are admitted to hospitals that frequently treat these illnesses they are less likely to die, according to research published in the New England Journal of Medicine.
Although cardiac computed tomography (cCT) has shown very good diagnostic accuracy for the detection of coronary artery disease, the physiologic significance of many lesions can be uncertain. Furthermore, the presence of calcified atherosclerotic plaque reduces the ability to differentiate significant stenosis from non obstructive plaque.
During conventional electro-cardiology, interference from electromagnetic fields (EMFs) tends to diminish image quality due to cardiac motion. To exclude that interference an acoustic cardiac triggering (ACT) approach, also called MR stethoscope, has been developed to trigger cardiac MRI at 7-Tesla.
Cardiologists are looking beyond on-screen images of the heart to extract data behind these scans that describe coronary dysfunctions and can reveal hard evidence of the cause of disease reports John Brosky.
Manufactured by Amsterdam-based company CardiaTech Holland BV, which specialises in defibrillators and AED trainer units, the CardiAid Automated External Defibrillator (AED) has been designed to provide electroshock treatment for sudden cardiac arrest (SCA).
Patients with atrial fibrillation, so at risk of stroke, are usually treated with medication to prevent coagulation. The Hanover Medical School (MHH) has devised an alternative treatment.
Western societies are struggling to pay for their ever increasing medical budgets. In the US up to 393 billion US-$ were spent in 2005 for cardiovascular diseases alone. Based on epidemiologic studies in primary prevention it is reasonable to estimate that 30% of coronary heart disease and stroke could be prevented by 2.5 hours of brisk walking per week.
Surviving a heart attack depends upon where you live in Europe. For cardiologists that is unacceptable. A majority of European countries can deliver life-saving primary percutaneous coronary interventions (P-PCI), yet too often these centres are closed over weekends or after working hours - when 50% of all myocardial infarctions occur.
Measuring left ventricle ejection fraction (LVEF) is the gold standard for determining the risk of cardiac death or sudden cardiac death after a myocardial infarction (MI). If LVEF is below 30%, a cardioverter-defibrillator is implanted to avoid such an event.
A potentially life-saving kiosk has been voted the best self-service application of 2009 by the Board of the European Association for Self-service (EAFS), during Kiosk Europe Expo 2009, held this May in parallel with Digital Signage Expo 2009 in Essen, Germany.
CardioPod will be installed in pharmacies and GP surgeries across England, allowing patients easy access to an NHS Health Check carried out by a trained professional, who will give expert advice on their cardiovascular risk score and what action they can take to reduce the risk of heart disease, stroke, type II diabetes and kidney disease.
The role of magnetic resonance imaging (MRI) to assess the effect of therapy in patients with acute myocardial infarction was demonstrated in a series of papers presented at the 12th Annual Scientific Sessions of the Society for Cardiovascular Magnetic Resonance (SCMR).
In April, the 75th annual congress of the German Cardiac Society (DGK) was considered a great success, drawing in some 7,900 specialists.
'There is no proof that some new procedures are better than the conventional ones or than clinical examination'
The role of magnetic resonance imaging (MRI) to assess the effect of therapy in patients with acute myocardial infarction was demonstrated in a series of papers during the 12th Annual Scientific Sessions of the Society for Cardiovascular Magnetic Resonance (SCMR), held in Orlando, Fla. USA (29 Jan - 1 Feb).
Less acute heart attacks in Italy five months after the introduction of a smoking ban in indoor public places.
The obesity epidemic is increasingly affecting young teens worldwide. In the USA the epidemic is well-established: more than 17% of children are obese and about a third of those have high blood pressure, which places them at risk for premature heart disease.
Maquet has launched Cardiohelp, the world's smallest, lightest heart-lung machine, that can not only provide a total therapy solution for heart surgery, cardiology, intensive and emergency care, but also, due to its suitcase size and 10 kg weigh, the device can be carried by just one person onto a helicopter or ambulance for mobile use.
